Overview of Dr. Dewdney
Dr. Summer Dewdney is an obstetrician/gynecologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush-Copley Medical Center, Rush Oak Park Hospital, and MetroSouth Medical Center. She received her medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 13 years. Dr. Dewdney accepts several types of health insurance, listed below. She is one of 177 doctors at Rush University Medical Center and one of 39 doctors at Rush Oak Park Hospital who specialize in Obstetrics & Gynecology. She has more than 30 publications and over 450 citings.
Office
1725 W Harrison St
Suite 842
Chicago, IL 60612
Education & Training
- University of ChicagoResidency, Obstetrics and Gynecology, 2004 - 2008
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004
Certifications & Licensure
- IL State Medical License 2004 - 2026
- MO State Medical License 2008 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) Start of enrollment: 2022 Dec 27
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsPhase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Onc...Larry J Copeland, Mark F Brady, Robert A Burger, William H Rodgers, Helen Q Huang
Journal of Clinical Oncology. 2022-12-10 - 47 citationsMutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.Kimberly K. Leslie, Virginia L. Filiaci, Adrianne R. Mallen, Kristina W. Thiel, Eric J. Devor
Gynecologic Oncology. 2021-04-01 - 49 citationsA phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peri...Bradley J. Monk, James Kauderer, Katherine M. Moxley, Albert J. Bonebrake, Summer B. Dewdney
Gynecologic Oncology. 2018-12-01
Press Mentions
- Ovarian Cancer Awareness Month: Survivor, Doctors Want Women to Know the Signs, SymptomsSeptember 4th, 2020
- One Cancer Is Almost 100% Preventable. And Chicago Is Making a Move to Eradicate ItFebruary 4th, 2020
Professional Memberships
- Fellow
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: